SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function is a research paper published in Nature Immunology (2020). On theSindex it has a DataRank of 1.0. It has been cited 990 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.0
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: 75N93019C00062
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: R01 AI127828
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: R01 AI130591
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: R35 HL145242
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: F32 AI138392
United States Department of Defense | Defense Advanced Research Projects Agency
Grant: HR001117S0019
Peromysus leucopus and Mus musculus transcriptomic analysis of lungs infected with Sars-CoV-2
Additional file 3 of Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
Additional file 3 of Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
Additional file 1 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 1 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 6 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 6 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 5 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 3 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 4 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 4 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 5 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 3 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 2 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 2 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Additional file 2 of Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
Additional file 1 of Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
Additional file 2 of Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
Additional file 1 of Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice